Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John S Partilla

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Journal of Medicinal Chemistry|April 3, 2008
Herkinorin analogues with differential beta-arrestin-2 interactionsKevin Tidgewell, Chad E Groer, Wayne W Harding, et al.
Journal of Medicinal Chemistry|March 3, 2006
Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivityElisabeth Greiner, Terrence L Boos, Thomas E Prisinzano, et al.
Drug Testing and Analysis|January 20, 2017
Analytical characterization and pharmacological evaluation of the new psychoactive substance 4-fluoromethylphenidate (4F-MPH) and differentiation between the (±)-threo and (±)-erythro diastereomersGavin McLaughlin, Noreen Morris, Pierce V Kavanagh, et al.
Neuropharmacology|October 10, 2017
Fluorinated phenmetrazine "legal highs" act as substrates for high-affinity monoamine transporters of the SLC6 familyFelix P Mayer, Nadine V Burchardt, Ann M Decker, et al.
ACS Chemical Neuroscience|December 5, 2024
Serotonin 1A Receptors Modulate Serotonin 2A Receptor-Mediated Behavioral Effects of 5-Methoxy-<i>N</i>,<i>N</i>-dimethyltryptamine Analogs in MiceGrant C Glatfelter, Allison A Clark, Natalie G Cavalco, et al.
British Journal of Pharmacology|September 27, 2014
Stereochemistry of mephedrone neuropharmacology: enantiomer-specific behavioural and neurochemical effects in ratsRyan A Gregg, Michael H Baumann, John S Partilla, et al.
Drug Testing and Analysis|October 22, 2014
Synthesis, characterization, and monoamine transporter activity of the new psychoactive substance 3',4'-methylenedioxy-4-methylaminorex (MDMAR)Gavin McLaughlin, Noreen Morris, Pierce V Kavanagh, et al.
ACS Chemical Neuroscience|May 27, 2026
Serotonin Transporter Blockade Reduces the Psychedelic-Like Effects of 4-Methoxy-<i>N</i>-methyl-<i>N</i>-isopropyltryptamine and Related AnalogsGrant C Glatfelter, Serena S Schalk, Donna Walther, et al.
Molecular Pharmacology|November 1, 2015
Binding Mode Selection Determines the Action of Ecstasy Homologs at Monoamine TransportersWalter Sandtner, Thomas Stockner, Peter S Hasenhuetl, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 18, 2012
Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' productsMichael H Baumann, John S Partilla, Kurt R Lehner, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Journal of Medicinal Chemistry|April 3, 2008
Herkinorin analogues with differential beta-arrestin-2 interactionsKevin Tidgewell, Chad E Groer, Wayne W Harding, et al.
Journal of Medicinal Chemistry|March 3, 2006
Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivityElisabeth Greiner, Terrence L Boos, Thomas E Prisinzano, et al.
Drug Testing and Analysis|January 20, 2017
Analytical characterization and pharmacological evaluation of the new psychoactive substance 4-fluoromethylphenidate (4F-MPH) and differentiation between the (±)-threo and (±)-erythro diastereomersGavin McLaughlin, Noreen Morris, Pierce V Kavanagh, et al.
Neuropharmacology|October 10, 2017
Fluorinated phenmetrazine "legal highs" act as substrates for high-affinity monoamine transporters of the SLC6 familyFelix P Mayer, Nadine V Burchardt, Ann M Decker, et al.
ACS Chemical Neuroscience|December 5, 2024
Serotonin 1A Receptors Modulate Serotonin 2A Receptor-Mediated Behavioral Effects of 5-Methoxy-<i>N</i>,<i>N</i>-dimethyltryptamine Analogs in MiceGrant C Glatfelter, Allison A Clark, Natalie G Cavalco, et al.
British Journal of Pharmacology|September 27, 2014
Stereochemistry of mephedrone neuropharmacology: enantiomer-specific behavioural and neurochemical effects in ratsRyan A Gregg, Michael H Baumann, John S Partilla, et al.
Drug Testing and Analysis|October 22, 2014
Synthesis, characterization, and monoamine transporter activity of the new psychoactive substance 3',4'-methylenedioxy-4-methylaminorex (MDMAR)Gavin McLaughlin, Noreen Morris, Pierce V Kavanagh, et al.
ACS Chemical Neuroscience|May 27, 2026
Serotonin Transporter Blockade Reduces the Psychedelic-Like Effects of 4-Methoxy-<i>N</i>-methyl-<i>N</i>-isopropyltryptamine and Related AnalogsGrant C Glatfelter, Serena S Schalk, Donna Walther, et al.
Molecular Pharmacology|November 1, 2015
Binding Mode Selection Determines the Action of Ecstasy Homologs at Monoamine TransportersWalter Sandtner, Thomas Stockner, Peter S Hasenhuetl, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 18, 2012
Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' productsMichael H Baumann, John S Partilla, Kurt R Lehner, et al.
Pageof 7